Gennex Laboratories Ltd.
12.18+0.0 (+0.25%)
26 Aug, 12:00 AM
Annual Reports and Financial Documents
Gennex Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
Corporate Announcements and Regulatory Filings
Gennex Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
- Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended June 30, 2026In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ....
- Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The Unaudited Financial ....
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018With reference to the captioned subject matter, pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018, we hereby submit the certificate received from the M/s R&D Infotech Private ....
- Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June ....
- Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June ....
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 10, 2026 for Premier Fiscal Services Pvt Ltd
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 10, 2026 for Premier Fiscal Services Pvt Ltd
- Board Meeting Intimation for Consideration And Approval Of The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve With reference to the above ....
- Notice Convening Extraordinary General Meeting (EGM) To Be Held On Tuesday, May 12, 2026 Through VC And OAVMPursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 read with Schedule III and in furtherance to our intimation date April 16, 2026 and revised intimation dated April 17, 2026, we ....
Frequently Asked Questions
Where can I download the annual report of Gennex Laboratories Ltd.?
Annual reports of Gennex Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Gennex Laboratories Ltd.?
Quarterly earnings results and presentations of Gennex Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Gennex Laboratories Ltd. publish earnings call transcripts?
Earnings call transcripts of Gennex Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Gennex Laboratories Ltd.?
Investor presentations and annual day presentations of Gennex Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Gennex Laboratories Ltd.?
Corporate announcements and regulatory filings of Gennex Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Gennex Laboratories Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Gennex Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Gennex Laboratories Ltd.?
The ISIN (International Securities Identification Number) of Gennex Laboratories Ltd. is INE509C01026. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Gennex Laboratories Ltd. listed?
Gennex Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is GENNEX and the BSE code is -.
Where can I find the shareholding pattern of Gennex Laboratories Ltd.?
The quarterly shareholding pattern of Gennex Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Gennex Laboratories Ltd. on Sharpely?
Share price data for Gennex Laboratories Ltd. is updated as of 26 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.